ARCHIVES

CCOP Review Committee Member Objects To “Unwarranted Criticism”

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

Research Triangles Lands Plant Drug Contract Renewal

April 9, 1976

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

Caplan: NEJM Should Go “The Extra Moral Mile”

January 9, 2009

In Brief: King Faisal Prize Next Year Will Be Awarded For Leukemia Research; Yarbro Wins Fulbirght

March 20, 1987

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

NCI To Seek Proposals For Less Invasive Detection, Diagnosis, Treatment Technologies

July 3, 1998